Enter Domain Name:
algorithmepharm.com: Algorithme Pharma
Algorithme Pharma is an FDA-audited, full-service contract research organization specializing in phase 1 studies, including bioavailability studies, bioequivalence studies, dose-ranging studies, drug/drug interaction studies, first in man studies, pharmacodynamic studies and pharmacokinetic studies. Algorithme Parma has completed more than 500 studies to date, for companies in the pharmaceutical, generic pharmaceutical and biotechnology industries in the US, Canada, Europe and other countries.

Algorithme Pharma

Description: Algorithme Pharma is an FDA-audited, full-service contract research organization specializing in phase 1 studies, including bioavailability studies, bioequivalence studies, dose-ranging studies, drug/drug interaction studies, first in man studies, pharmacodynamic studies and pharmacokinetic studies. Algorithme Parma has completed more than 500 studies to date, for companies in the pharmaceutical, generic pharmaceutical and biotechnology industries in the US, Canada, Europe and other countries.

Keywords: Montréal (pharma Montréal), 21 CFR conforme partie-11, 21 CFR part-11 compliant, 50 Best Managed Companies, 50 Sociétés les mieux Gérées, AAPS, Abbreviated New Drug Applications, ACT, AFSSAPS, Agence Nationale de Surveillance Sanitaire du Brésil, algo, algopharm, Algorithme Pharma Inc., algorythme, American Association of Pharmaceutical Scientists, American Society for Clinical Pharmacology and Therapeutics, American Society for Mass Spectrometry, analyse contractuelle, analyse de drogue, analyses dééchantillons, analyses de contrat, ANDA, ANVISA, Applied Clinical Trials (European Summit), ARCS, ASCPT, ASMS, Association of Regulatory and Clinical Scientists, Assurance Qualité, Bio analyse, bio international, bio statistiques, bioanalysis, bioanalysis services, Bioanalytical, Bioanalytique, Bioavailability, biodisponibilité, Bioequivalence, Bioéquivalence, biointernational, biostatistics, biostudies, Biotechnology City of Laval, blood draw, blood draws, blood sampling, Bonnes pratiques cliniques, Bonnes pratiques de laboratoires, BPC, Brazilian National Health Surveilance Agency, CDER, Center for Drug Evaluation and Research, CIH, Cité de la Biotechnologie, clinic, clinical operations, clinical outsourcing, clinical research, clinical study, clinical tests, clinical trial, Clinical Trial Design, clinical trials, clinique, Comité dééthique, compagnie pharmaceutique, compensatory indemnity, Conférence Internationale sur l'Harmonisation, contract, contract analysis, contract analytical, Contract research, contract research organisation, Contract research organization, contrat, CRO, CTD, Data management, DIA, docteurs, domaine pharmaceutique, Drug Information Association, drug testing, échantillon déurine, échantillon de sang, EGA, Eithics Committee, élaboration de protocoles, EMEA, Entreprise de Recherche Contractuelle, ERC, essai, essai clinique, essais cliniques, Essais sur volontaires, étude, études, études biologiques, études cliniques, European Generics medicines Association, European Medicine Evaluation Agency, examen, exigences réglementaires, FDA, FDC, FDC!, FIP, Food and Drug Administration, French Health Products Safety Agency, GCP, generic drugs, Generic Pharmaceutical Association, Gestions des données, gestions des projets, GLP, Good Clinical Practice, Good Laboratory Practice, GPA, Health Products and Food Branch, healthy subjects, HPFB, ICH, ICSE, IGPA, in vivo, IND, indemnité compensatoire, infirmiére, Institutional Review Board, International Conference on Harmonization, International Contract Services Expo, international Generic Pharmaceutical Alliance, International Newtech Development, International Pharmaceutical Federation, IRB, léAgence franéaise de sécurité sanitaire des produits de santé, laboratoire médical, laboratoires, laboratories, laboratory services, labs, Laval, médicament, médicaments, medication, medications, method development, méthode de développement, Montreal (Pharma Montreal), NDA, New Drug Application Process, nurse, Office of Generic Drugs, OGD, opérations cliniques, PABORD, Part-11 drug method, participant, participate, participer, PCERT, Pharma, pharmaceutical, Pharmaceutical & Biotech Outsourcing Research & Development Expo & Conference, pharmaceutical outsourcing, pharmacie, Pharmacocinétique, pharmacodynamics, pharmacodynamique, Pharmacokinetics, pharmacologie, pharmacy, Phase I, pilot, pivot, pivotal, population spéciale, populations particuliers, project management, Protocol development, QA, QC, Quality Assurance, Quality Control, recherche, recherche clinique, Recherche Contractuelle, recruitment, recrutement, réglements, regulatory, regulatory affairs, répertoire de gestions, research, sample analysis, Santé Canada, services de bio analyse, services de laboratoires, sous-traitance clinique, sous-traitance pharmaceutique, special population, Statistical Programming, statistics clinic, statistiques cliniques, studies, study, subject, sujet, sujet sain, systémes HPLC, test, tests, tests on volunteers, TGA, Therapeutic Goods Administration, Therapeutic Product Directorate, TPD, urine sample, vérification, volontaires cliniques, Algorithme Pharma, Algorithme Pharma Inc, Algorithme Pharma Inc., HPLC Systems, volontaire clinique, ICSE, IGPA, in vivo, IND, indemnité compensatoire, infirmiére, Institutional Review Board, International Conference on Harmonization, International Contract Services Expo, international Generic Pharmaceutical Alliance, International Newtech Development, International Pharmaceutical Federation, IRB, léAgence franéaise de sécurité sanitaire des produits de santé, laboratoire médical, laboratoires, labs, Laval, médicament, médicaments, méthode de développement, NDA, New Drug Application Process, Office of Generic Drugs, OGD, opérations cliniques, PABORD, Part-11 drug method, participant, participer, PCERT, Pharma, Pharmaceutical & Biotech Outsourcing research & Development Expo & Conference, pharmacie, Pharmacocinétique, pharmacodynamique, pharmacologie, Phase I, pivot, pivotal, population spéciale, populations particuliers, QA, QC, Quality Control, recherche, recherche clinique, Recherche Contractuelle, recrutement, réglements, répertoire de gestions, Santé Canada, services de bio analyse, services de laboratoires, sous-traitance clinique, sous-traitance pharmaceutique, Statistical Programming, statistiques cliniques, sujet, sujet sain, systémes HPLC, test, TGA, Therapeutic Goods Administration, Therapeutic Product Directorate, TPD, vérification, volontaires cliniques, Algorithme Pharma Inc., volontaire clinique

Tags: algorithmepharm, algorithme, pharma, rights, reserved, copyright, studies, pharmaceutical, drug,

Algorithmepharm.com

Content Revalency: Title: 100.00%   Description: 4.35%   Keywords: 0.69%  |  Document size: 9,030 bytes
More info: Whois - Trace Route - RBL Check
ALGORITHMEPHARM.COM - Site Location
Country/Flag CA Canada
City/Region/Zip Code , ,
Organization Videotron Ltee
Internet Service Provider Videotron Ltee
ALGORITHMEPHARM.COM - Domain Information
Domain ALGORITHMEPHARM.COM   [ Traceroute  RBL/DNSBL lookup ]
Registrar GODADDY.COM, LLC GoDaddy.com, LLC
Registrar URL http://registrar.godaddy.com
Whois server whois.godaddy.com
Created 17-Dec-2008
Updated 29-Dec-2015
Expires 17-Dec-2016
Time Left 0 days 0 hours 0 minutes
Status clientDeleteProhibited http://www.icann.org/epp#clientDeleteProhibited clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited clientUpdateProhibited http://www.icann.org/epp#clientUpdateProhibited clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited clientUpdateProhibited http://www.icann.org/epp#clientUpdateProhibited clientRenewProhibited http://www.icann.org/epp#clientRenewProhibited clientDeleteProhibited http://www.icann.org/epp#clientDeleteProhibited
DNS servers NS65.DOMAINCONTROL.COM   216.69.185.43
NS66.DOMAINCONTROL.COM   208.109.255.43
ALGORITHMEPHARM.COM - DNS Information
IP Address 207.96.225.40 ~ Whois - Trace Route - RBL Check
Domain Name Servers ns1.autolinq.com   149.56.45.216
ns1.psycode.com   107.161.6.111
Mail Exchange mail2.autolinq.com   107.161.6.120
mail1.autolinq.com   107.161.6.119
Site Response Header
Response HTTP/1.1 301 Moved Permanently
Server Apache/2.2.3 (CentOS)
Date Thu, 07 Apr 2011 16:48:28 GMT
Content-Type text/html; charset=UTF-8